Zenlabs Ethica Limited (BOM:530697)
19.75
-0.49 (-2.42%)
At close: Jan 21, 2026
Zenlabs Ethica Revenue
Zenlabs Ethica had revenue of 124.33M INR in the quarter ending September 30, 2025, a decrease of -6.88%. This brings the company's revenue in the last twelve months to 496.19M, down -12.40% year-over-year. In the fiscal year ending March 31, 2025, Zenlabs Ethica had annual revenue of 514.23M, down -12.19%.
Revenue (ttm)
496.19M
Revenue Growth
-12.40%
P/S Ratio
0.25
Revenue / Employee
7.63M
Employees
65
Market Cap
126.29M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 514.23M | -71.41M | -12.19% |
| Mar 31, 2024 | 585.63M | -83.23M | -12.44% |
| Mar 31, 2023 | 668.86M | -22.01M | -3.19% |
| Mar 31, 2022 | 690.88M | 124.48M | 21.98% |
| Mar 31, 2021 | 566.40M | -33.09M | -5.52% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dipna Pharmachem | 1.07B |
| Medico Intercontinental | 822.95M |
| Constronics Infra | 667.12M |
| Medistep Healthcare | 496.55M |
| Chandra Bhagat Pharma | 493.95M |
| Evoq Remedies | 407.29M |
| Muller & Phipps (India) | 72.38M |
| Pentokey Organy (India) | 66.52M |